Basf Corp, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IBUPROFEN, with a corresponding US DMF Number 8709.
Remarkably, this DMF maintains an Active status since its submission on September 10, 1990, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 05, 2013, and payment made on January 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II